Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

96 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46,679,856 shares of 141,783,702 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8,934,902 shares), MPM ASSET MANAGEMENT LLC (4,951,303 shares), Deep Track Capital, LP (3,500,000 shares), Vida Ventures Advisors, LLC (2,960,046 shares), CITADEL ADVISORS LLC (2,925,714 shares), Logos Global Management LP (2,900,000 shares), RA CAPITAL MANAGEMENT, L.P. (2,805,045 shares), BlackRock Inc. (2,474,427 shares), FRANKLIN RESOURCES INC (1,746,481 shares), and Point72 Asset Management, L.P. (1,366,400 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.